Jinna Cai

Title: Jinna Cai: Innovator in Gastric Acid-Related Treatments

Introduction

Jinna Cai is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the development of treatments for gastric acid-related diseases. With a total of 4 patents to his name, Cai's work is recognized for its innovative approach to addressing medical challenges.

Latest Patents

Cai's latest patents include a class of substituted pyrrolo[3,4-c]pyrazoles for treating gastric acid-related diseases. This innovative class is represented by a specific formula, which highlights its potential therapeutic applications. Another notable patent involves pyrrolopyrazole derivatives, which are described in a general formula. This patent outlines a preparation method and application in medicine, particularly as a gastric acid secretion inhibitor and a potassium-competitive acid blocker (P-CABs).

Career Highlights

Throughout his career, Jinna Cai has worked with several reputable companies, including Shanghai Medicilon Inc. and Medicilon Preclinical Research (Shanghai) LLC. His experience in these organizations has allowed him to advance his research and contribute to the development of new medical treatments.

Collaborations

Cai has collaborated with notable coworkers, including Feng Ren and Yongmei Xu, who have contributed to his research endeavors. Their combined expertise has played a crucial role in the success of his projects.

Conclusion

Jinna Cai's innovative work in the field of gastric acid-related treatments showcases his dedication to advancing medical science. His patents reflect a commitment to finding effective solutions for patients suffering from these conditions.